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Abstract
NMDA receptor-mediated glutamate transmission is required for several forms of neuronal 
plasticity. Its role in the neuronal responses to addictive drugs is an ongoing subject of 
investigation. We report here that the acute locomotor-stimulating effect of cocaine is absent in 
NMDA-receptor deficient mice (NR1-KD). In contrast, their acute responses to amphetamine and 
to direct dopamine receptor agonists are not significantly altered. The striking attenuation of 
cocaine's acute effects is not likely explained by alterations in the dopaminergic system of NR1-
KD mice, since most parameters of pre-and post-synaptic dopamine function are unchanged. 
Consistent with the behavioral findings, cocaine induces less c-Fos expression in the striatum of 
these mice, while amphetamine-induced c-Fos expression is intact. NR1-KD mice can become 
sensitized and display conditioned place preference to cocaine; however, these behaviors are 
attenuated and develop more slowly in mutant animals. Our results highlight the importance of 
NMDA receptor-mediated glutamatergic transmission specifically in cocaine actions, and support 
a hypothesis that cocaine and amphetamine elicit their effects through differential actions on 
signaling pathways.
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Introduction
Cocaine and amphetamine are thought to exert their stimulant and addictive effects by 
elevating synaptic concentrations of monoamines, particularly dopamine, in brain reward 
areas. Cocaine elevates dopamine by preventing the reuptake and clearance of the stimulated 
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release of dopamine, whereas amphetamine elevates dopamine not only by acting as a 
dopamine transporter substrate and competitively inhibiting dopamine transport, but also by 
dissipating the vesicular storage and reversing plasma membrane monoamine transporters, 
thus releasing the vesicular pool of stored dopamine into the synapse (Amara and Kuhar, 
1993; Jones et al 1998; Sulzer et al 2005).
Although these psychostimulants do not act directly on glutamate receptors, their 
physiological actions are influenced by glutamatergic transmission. This is due in part to the 
convergence and integration of dopaminergic and glutamatergic signals within neurons of 
the striatum and nucleus accumbens, brain regions that regulate locomotion and motivated 
behaviors. Pharmacological disruption of glutamate receptor signaling has been reported to 
modify the acute behavioral effects of cocaine (Karler and Calder, 1992; Kenny and Markou, 
2004). Furthermore, glutamate-mediated plasticity is implicated in the development of 
addiction (Thomas et al 2001; Nestler, 2001; Hyman and Malenka, 2001; White, 2002). 
NMDA-type glutamate receptors are crucial components mediating the neuronal plasticity 
that accompanies spatial learning and memory (Tang et al 1999; Shimizu et al 2000). 
Common molecular components, including the NMDA receptor, might also determine the 
lasting changes in the brain's reward system that cause addiction. Recent studies have 
investigated the impact of psychostimulant exposure on the electrophysiological properties 
of striatal neurons and the number of AMPA-type glutamate receptors that are trafficked to 
and from striatal synapses (Thomas et al 2001; Beurrier and Malenka, 2002). NMDA 
receptors can potentially regulate the number of AMPA receptors at the synapse through a 
calcium signaling cascade that controls the phosphorylation of the GluR1 subunit of AMPA 
receptors by protein kinase A (Ehlers 2000, Beattie et al 2000; Snyder et al 2005).
Early neuronal plasticity from psychostimulant exposure can be manifested behaviorally as 
sensitization, where each consecutive exposure to the reinforcing drug leads to an enhanced 
response such as locomotor activation in rodents (Segal and Mandell, 1974; Post and Rose, 
1976). This altered state of responsiveness involves long-lasting changes in gene expression, 
electrophysiological properties, and even morphology of striatal medium spiny neurons (Yao 
et al 2004; Thomas et al 2001; Nestler, 2001; Bibb et al 2001; Robinson and Kolb, 1997; 
Koob et al 1998). Several groups have reported disrupted sensitization to psychostimulants 
and dopaminergic agonists using pharmacological tools to block NMDA receptor function 
(Li et al 1999; Haracz et al 1995; Kalivas and Alesdatter, 1993; Stewart and Druhan, 1993; 
Wolf and Jeziorski, 1993; Karler et al 1989); however, variations in the timing and context of 
NMDA antagonist administration may affect different aspects of the biological process 
underlying sensitization (Tzschentke and Schmidt, 1998; Ranaldi et al 2000).
To clarify the role of NMDA receptor signaling in different psychostimulant actions, we 
studied the effects of cocaine and amphetamine in mice with reduced expression of the 
essential NR1 subunit of the NMDA receptor (Mohn et al 1999) caused by hypomorphic 
mutation of Grin1. The NR1 knockdown mice (NR1-KD) survive into adulthood and have a 
phenotype resembling pharmacological blockade of NMDA receptors. These include 
increased locomotor and stereotypic activity and deficits in social interactions, while 
showing normal extracellular levels, storage, and metabolism of the monoamines dopamine 
and serotonin. In this study we found that the acute effects of cocaine were markedly 
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diminished in NR1-KD mice, whereas the response to amphetamine was unaltered. 
Repeated cocaine administration led to a delayed development of sensitization, and the 
extent of sensitization was less than what is seen in wildtype mice. However, the rewarding 
properties of cocaine and amphetamine were preserved in NMDA receptor deficient mice.
Methods and Materials
Animals
All studies were conducted with an approved protocol from the Duke University Institutional 
Animal Care and Use Committee and in compliance with NIH guidelines for the care and 
use of experimental animals. The generation of NR1-KD mice has been described 
previously (Mohn et al 1999). Experimental animals were derived by intercrossing 
C57Bl6/129Ola/DBA2 mice that were heterozygous for the altered Grin1 allele. Animals 
were housed 4-5/cage, maintained under standard lab conditions (12h light/dark cycle) with 
food and water provided ad libitum, and tested at 10-16 weeks of age. Wildtype and mutant 
groups were matched for age and gender in all experiments, and all drugs and doses were 
tested in drug-naïve animals.
Western blot
Brain tissue from animals sacrificed by cervical dislocation was prepared by rapid 
postmortem dissection and freezing. Midbrain regions were dissected by isolating a 1 mm 
coronal section at –3 Bregma and removing the 1 mm3 region from each hemisphere where 
the substantia nigra and ventral tegmental areas are located. Striatum, hippocampus, 
prefrontal cortex, and midbrain were homogenized in 50 mM Tris pH 7.4, 150 mM NaCl, 
2% SDS, 1 mM EDTA and protease inhibitor cocktail (Complete Mini, Roche, Mannheim, 
Germany). 20-40 μg of protein extracts were resolved with a denaturing 10% acrylamide gel 
and transferred to nitrocellulose membranes before incubating with the appropriate 
antibodies. Blots were incubated overnight at 4°C with primary antibodies against NR1, 
NR2A, NR2B, GluR1, GluR2/3 (Upstate Biotechnology, Lake Placid, NY) or actin 
(Chemicon, Temecula, CA). Following incubation with peroxidase-conjugated secondary 
antibodies, protein levels were detected with chemiluminescence (SuperSignal West Pico, 
Pierce, Rockford, IL) and compared by densitometry using Scion Image (Scion Corporation, 
Frederick, MD).
Locomotor activity measurements
Locomotion was evaluated in an automated Omnitech Digiscan apparatus (AccuScan 
Instruments, Columbus, OH) under illuminated conditions as described previously 
(Gainetdinov et al 1999). Individual activity data were collected at 5 min intervals. 
Locomotor activity was measured as the total distance traveled. Before drug administration, 
mice were habituated to the activity monitor for 60 min. Amphetamine, cocaine and 
quinpirole were dissolved in saline, SKF-81297 was dissolved in distilled water, and all 
drugs were administered intraperitoneally (i.p.) in a volume of 10 ml/kg. Control animals 
received a corresponding volume of saline. All drugs were obtained from Sigma (St. Louis, 
MO).
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Mice were anesthetized with chloral hydrate (400 mg/kg i.p.) and placed in a stereotaxic 
frame. Dialysis probes (2-mm membrane length, 0.24-mm o.d., Cuprophane, 6-kDa cutoff, 
CMA-11; CMA/Microdialysis, Solna, Sweden) were implanted in the right striatum. The 
stereotaxic coordinates for implantation of microdialysis probes were 0.0 mm AP, -−4.4 DV 
mm, L2.5 relative to bregma. After surgery, animals were returned to their home cages with 
free access to food and water. At least 24 hours after surgery, the dialysis probe was 
connected to a syringe pump and perfused at 1 μl/min with artificial cerebrospinal fluid (147 
mM NaCl/2.7 mM KCl/1.2 mM CaCl2/0.85 mM MgCl2) (CMA/Microdialysis). After an 
equilibration period of 1 hour, the perfusates were collected every 20 min. At least four 
control samples were taken before amphetamine, cocaine, or saline was administered i.p. 
Data are presented as a percentage of the basal levels (as mean±S.E.M.). Perfusate samples 
were assayed for dopamine with the use of HPLC with electrochemical detection as 
described (Jones et al 1998; Gainetdinov et al 1999).
Radioligand binding
Striatum, hippocampus, or midbrain regions were rapidly dissected on ice and frozen in 
liquid nitrogen. [3H]SCH23390 binding to D1 receptors was assessed as described 
previously (Bowden et al 1997). Briefly, striata were homogenized in 50 mM Tris-HCl, pH 
7.4, centrifuged and resuspended twice to remove endogenous dopamine. Membranes were 
incubated for 1 hour at room temperature in a buffer containing 50 mM Tris-HCl, pH 7.4, 
120 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 100 nM ketanserin, and increasing 
concentrations of the radioligand for saturation analysis. Nonspecific binding was 
determined with 10 μM cis-flupenthixol. Bound ligand was separated from free by rapid 
filtration onto Whatman GF/C filters washed with ice-cold Tris buffer. Saturation curves 
were fitted by nonlinear regression using GraphPad Prism software (GraphPad Software 
Inc., San Diego, CA). [3H]quinpirole binding to D2 receptors was assessed similarly 
(Malmberg and Mohell, 1995); the binding buffer contained 50 mM Tris-HCl, pH 7.4, 120 
mM NaCl, 1 mM EDTA, 5 mM KCl, and 4 mM MgCl2, and nonspecific binding was 
determined with 1 μM (+)-Butaclamol. For [3H]CFT ([3H]WIN 35,428) binding (Madras et 
al 1989), membranes were incubated for 2 hours on ice in a buffer containing 50 mM Tris-
HCl, pH 7.4, 120 mM NaCl, 4 nM [3H]CFT and increasing concentrations of cold CFT for 
homologous competition analysis. Filtration was done using Whatman GF/B filters 
presoaked in 0.1% bovine serum albumin. All radioligands were obtained from New 
England Nuclear/Perkin Elmer Life Sciences (Waltham, MA).
Immunohistochemistry
Mice were given i.p. injections of saline, cocaine (20 mg/kg) or amphetamine (3 mg/kg). 
Ninety minutes later they were anaesthetized with chloral hydrate (400 mg/kg i.p.) and 
perfused transcardially with 0.9% saline, followed by 4% paraformaldehyde in phosphate 
buffered saline (PBS) (pH 7.4 at 4 °C). Brains were post-fixed for 1-3 days at 4°C and 
cryoprotected in 10% sucrose. Free-floating 40 μm sections were incubated 24 hours at 4°C 
with the primary antisera anti-DARPP-32 (1:3000, C11521, BD Transduction Laboratories, 
Bedford, MA) or two days at 4 °C with anti-c-Fos (1:5000, Ab-5, Oncogene, San Diego, 
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CA) followed by appropriate labeled secondary antibody (Vector Laboratories, Burlingame, 
CA) for 30 min at room temperature. Slides were viewed on a laser scanning Zeiss confocal 
microscope (LSM-510, Carl Zeiss, Oberkochen, Germany) and the IPLab software for 
Windows v3.0 was used for image processing and analysis (BioVision Technologies, Inc). 
Strict stereological methods were performed for the assessment of the number of DARPP-32 
and c-Fos positive cells as previously described (Cyr et al 2005). Four adjacent sections have 
been considered from each animal (+1.20 to +1.04 from bregma) and the striatum was 
divided into its dorsal and ventral parts. Anatomical landmarks such as aspect, size and 
situation of the anterior commissures, corpus callosum, septum, lateral ventricles, striatum 
and nucleus accumben, were used to ensure that levels studied were similar within and 
between groups. The average number of positive cells per section, for both the dorsal and 
ventral part of striatum, was from two 0.01 mm3 (0.5mm × 0.5mm × 40μm) counting areas 
per hemispheres (40× objective), one systematically placed in the lateral part (half exterior) 
of the striatum and one in its medial part (half interior). The final estimation of the positive 
cells number per animal was the average of positive neurons per mm3 sampled in both 
hemispheres of the 4 adjacent sections as described above ± S.E.M. from 4 mice/groups. All 
sections were coded and quantitative analyses of specimens were performed without the 
knowledge of genotypes.
Conditioned place preference
Place preference experiments were conducted in a commercially available apparatus (MED 
Associates MED-PP-MS, Georgia, VT) in the paradigm used in Medvedev et al (2005). The 
apparatus had two test chambers that were distinguished by different wall colors and 
patterns, floor texture, and olfactory cues. Experiments included three phases: pre-
conditioning, conditioning and testing phases. During preconditioning, mice were allowed 
free access for 30 min to both chambers and the time spent in each chamber was recorded. 
On the next day, cocaine (20 mg/kg i.p.) was injected and mice were placed in the less 
preferred chamber for 30 min; the following day saline injection was paired with the other 
chamber. After these two conditioning days, test sessions were run in which mice were given 
free access to both chambers and time spent in each was recorded. This cycle of 
conditioning and testing was repeated 3 times to assess the effect of repeated drug exposure. 
Amphetamine CPP was assessed similarly, except that the conditioning phase consisted of 
six consecutive days during which mice were administered saline or amphetamine 2 mg/kg 
i.p. on alternate days. This conditioning was followed by one test session to measure place 
preference.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (GraphPad Software, San Diego, 
CA). Biochemical data are expressed as the means±SEM, and were analyzed by paired 
Student's t-test. Behavioral data are expressed as means±SEM, and were analyzed by one-
way ANOVA followed by Newman-Keuls test or by two-tailed Student's t-test. For cocaine 
and amphetamine sensitization experiments, data were analyzed by one-way repeated 
measures ANOVA with Newman-Keuls post hoc test. For cocaine conditioned place 
preference, two-way repeated measures ANOVA was first performed to identify treatment 
effect, genotype effect, and genotype×treatment interaction. This was followed by one-way 
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repeated measures ANOVA within genotype to track the development of conditioned place 
preference, and non-paired two-tailed t-test to compare genotypes on specific treatment 
days. For amphetamine place preference, two-way repeated measures ANOVA was used to 
identify treatment effect, followed by paired two-tailed t-test to test significance of treatment 
effect for each genotype. Statistical significance was determined by probability values less 
than 0.05.
Results
Glutamate receptor levels in various brain regions of NR1-KD mice
Gene expression of the NR1 subunit in homozygous NR1-KD mice has previously been 
reported to be 5-10% of the wildtype levels (Mohn et al 1999). This characterization was 
extended to determine whether there were regional differences in NMDA receptor level, and 
whether the levels of other components of glutamate transmission were affected by this 
mutation. Levels of NMDA receptors in prefrontal cortex, striatum and hippocampus of 
wildtype and NR1-KD mice were assessed by western blot analysis, and revealed that NR2A 
and NR2B subunits of the NMDA receptor were also substantially reduced to approximately 
10-20% as a consequence of NR1 deficiency (Figure 1). Normally the NR1 subunit is 
present in excess and is retained in the ER or rapidly degraded when not assembled with an 
NR2 subunit (Huh and Wenthold, 1999; Scott et al 2001). In the NR1-KD mice, the NR1 
subunit must be the limiting factor in the assembly of heteromeric NMDA receptors. The 
results of the western blot analysis showed that NR2 levels are decreased, perhaps as a result 
of degradation, when NR1 levels are insufficient. No overall changes in AMPA glutamate 
receptor protein levels were detected by western blot. Total levels of GluR1 and GluR2/3 
subunits appeared unchanged in the striatum, frontal cortex, and hippocampus of NR1-KD 
mice (Figure 1).
These studies were repeated to measure glutamate receptor levels in the midbrain substantia 
nigra and ventral tegmental area, where dopaminergic cell bodies are located (Figure 1). As 
in other brain regions, NR1 protein is present at approximately 10% of wildtype level, and 
AMPA receptor subunit GluR1 levels are not altered in NR1-KD mice compared to 
wildtypes.
Behavioral effects of acute cocaine and amphetamine administration in NR1-KD mice
Induction of locomotor hyperactivity is the hallmark behavioral effect of psychostimulants 
in rodents. Thus, locomotor activity of NR1-KD mice and their wildtype littermates was 
measured following cocaine administration. Basal locomotor hyperactivity in NR1-KD mice 
is evident after saline injection, as reported previously (Mohn et al 1999) (Figure 2). 
Whereas cocaine produced a dose-dependent increase in the locomotor activity in wildtype 
mice, it did not produce a statistically significant increase in NR1-KD mice with doses up to 
40 mg/kg intraperitoneally (i.p.) (Figure 2). Higher doses could not be tested as they rapidly 
induce seizures in both wildtype and NR1-KD mice. To test whether this observation could 
be generalized to other psychostimulants, amphetamine was used in a similar paradigm. 
Amphetamine-induced hyperactivity was comparable between wildtype and NR1-KD mice 
Ramsey et al. Page 6













at a dose of 3 mg/kg i.p. (Figure 2). These results indicate that the acute behavioral response 
to cocaine, but not to amphetamine, is severely impaired in NR1-KD mice.
Presynaptic dopamine function in the striatum of NR1-KD mice
The basal extracellular levels and turnover of dopamine were previously found to be normal 
in NR1-KD mice (Mohn et al 1999); however, psychostimulant-induced increases in 
dopamine could be altered. To assess this, in vivo microdialysis was performed in the 
striatum of freely moving mice after the administration of saline, cocaine (20 mg/kg i.p.) and 
amphetamine (3 mg/kg i.p.). In agreement with the previous study, the basal dialysate 
concentrations of dopamine were not different between genotypes. Furthermore, there were 
no significant differences between NR1-KD and wildtype mice in the elevations of 
extracellular dopamine levels produced by cocaine or amphetamine (Figure 3). In line with 
these results, the specific binding of the selective cocaine analog [3H]2-β-carbomethoxy-3β-
(4-fluorophenyl)tropane ([3H]CFT) to the dopamine transporter in striatal membranes was 
not significantly different between NR1-KD and wildtype mice (Figure 3), indicating that 
the number and affinity of psychostimulant binding sites and/or dopaminergic nerve 
terminals are not changed (Soucy et al 1997). In summary, the differential behavioral effects 
of cocaine and amphetamine in NR1-KD mice cannot be explained by presynaptic 
alterations in neurochemical parameters of the dopaminergic system.
Dopamine receptors in NR1-KD mice
Altered expression of NMDA receptors in medium spiny neurons could possibly affect the 
regulation of postsynaptic D1 and D2 dopamine receptors in the striatum (Scott et al 2002; 
Gandolfi and Dall'Olio, 1993; Micheletti et al 1992), thus modulating the effects of 
psychostimulants (Xu et al 1994; Moratalla et al 1996a; Chausmer and Katz, 2001). This 
possibility was studied by quantifying receptor levels with radioligand binding, and by 
measuring the behavioral effects of direct dopamine receptor agonists. The specific binding 
of D1 receptor radioligand [3H]SCH23390 to striatal membranes is similar in NR1-KD and 
wildtype mice (Figure 4). Accordingly, the full D1 receptor agonist SKF- 81297 produces a 
comparable increase in the locomotor activity of NR1-KD and wildtype mice.
D2 dopamine receptor function was assessed with the D2/D3 agonist quinpirole. D2 receptor 
levels measured by radioligand binding with [3H]quinpirole are similar in striatal membrane 
preparations from wildtype and NR1-KD mice (Figure 4). Furthermore, no difference in the 
locomotor effects of the D2 agonist quinpirole was observed between NR1-KD and wildtype 
mice. Quinpirole inhibited locomotor activity to the same extent (Figure 4), and when the 
activity is expressed as a percentage of the basal activity, there is no significant difference 
between wildtype and NR1-KD animals (data not shown).
Biochemical measures of postsynaptic response to psychostimulants
Administration of either cocaine or amphetamine induces the expression of the Fos family of 
transcription factors in the brain (Nestler, 2001; Koob et al 1998; Graybiel et al 1990). 
However, the patterns of induction in the striatum are different, and this has been 
hypothesized to be due to the differential contribution of the glutamatergic corticostriatal 
pathway (Moratalla et al 1996a,b; Graybiel et al 1990; Tan et al 2000). To test whether this 
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hypothesis might relate to the observed differential effects of cocaine and amphetamine in 
NR1-KD mice, we assessed the patterns of c-fos expression after treatment with the two 
drugs.
Supporting our hypothesis and the behavioral results, amphetamine-induced c-fos protein 
expression in the striatum was similar in NR1-KD and wildtype mice (Figure 5). As reported 
previously (Moratalla et al 1996a,b; Graybiel et al 1990; Tan et al 2000), cocaine induced c-
fos in dorsal and ventral regions of the striatum in wildtype mice (Figure 5). The number of 
c-fos positive neurons in ventral striatal regions was not significantly different between the 
two genotypes. However, the number of neurons with cocaine-induced c-fos expression was 
significantly lower in the dorsal striatum of NR1-KD mice (−38%). Dorsal striatum is 
related to sensorimotor functions (Heimer et al 1995) and the difference in this region could 
explain the different locomotor response to cocaine. The remaining ability of cocaine to 
induce c-fos in NR1-KD mice is presumably mediated by D1 receptor stimulation. 
Immunolabeling with anti-DARPP-32 (dopamine and cAMP-regulated phosphoprotein, 32 
kDa) antibody confirmed that similar numbers of medium spiny neurons were present in 
NR1-KD and wildtype brains (data not shown) (Greengard, 2001; Anderson and Reiner, 
1991), demonstrating that reduced c-fos induction was not a result of decreased neuronal 
number in NR1-KD mice.
These data provide a biochemical correlate to the differential behavioral effects of cocaine 
and amphetamine in NR1-KD mice. They also suggest that the activation of the 
corticostriatal pathway is critical for the stimulatory effects of cocaine, as its ability to 
induce c-fos expression is diminished in mice with reduced NMDA receptor expression. 
Although dopamine- and amphetamine–stimulated c-fos expression in the striatum is also 
affected by NMDA receptor –mediated glutamatergic signaling from the frontal cortex 
(Konradi et al 1996; Cenci and Björklund, 1993; Badiani et al 1998), our results are in line 
with reports suggesting that amphetamine c-fos induction might be less sensitive to 
decreased NMDA receptor function (Dalia and Wallace, 1995; Morelli et al 1997; Ganguly 
and Keefe, 2000; Miyamoto S et al 2004).
Cocaine sensitization and conditioned place preference in NR1-KD mice
Given the reduced acute effects of cocaine in NR1-KD mice, it was of interest to examine 
the behavioral responses to repeated cocaine exposures. Pharmacological blockade of 
NMDA receptors has been reported to disrupt the development and expression of behavioral 
sensitization to the locomotor-stimulant effects of cocaine and other psychostimulants 
(Vanderschuren and Kalivas, 2000; Wolf, 1998). To assess whether the same is true in a 
genetic model of NMDA receptor deficiency, a regimen to induce cocaine sensitization was 
performed. NR1-KD and wildtype mice were given daily cocaine injections (20 mg/kg i.p.) 
on five consecutive days and tested for the locomotor activity on the seventh day using the 
same dose. Cocaine was administered daily in the same context, the locomotor activity 
chambers, after a 30 minute habituation period. Drug response was measured both by total 
distance traveled and by fold activation relative to saline injection to account for differences 
in basal activity and habituation to the testing apparatus over time.
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Wildtype mice already showed full sensitization to cocaine by the third day of cocaine 
exposure (Figure 6). In NR1-KD mice, however, locomotor responses to cocaine increased 
modestly until day seven of the sensitization protocol. On the seventh day of testing, NR1-
KD mice showed a diminished response to cocaine as compared to wildtype animals, but a 
level of sensitization was observed nonetheless. Acquisition of cocaine sensitization in NR1-
KD animals was not accompanied by a compensatory increase in striatal NMDA receptor 
levels (data not shown). These results demonstrate that compromised NMDA receptor 
function leads to delays in the acquisition of a sensitized state and to attenuation of the 
extent of sensitization.
In contrast, the development of behavioral sensitization to amphetamine was similar in 
wildtype and NR1-KD mice. Daily administration of 2 mg/kg amphetamine led to a 
comparable increase in the fold activation of locomotor response in both genotypes (Figure 
7). NR1-KD mice did not show delays in amphetamine sensitization: in fact a significant 
increase in locomotor response was seen on the second exposure in NR1-KD mice, while 
this increase did not reach significance until the fourth exposure in wildype mice.
To study whether the rewarding properties of cocaine were altered, responses to cocaine (20 
mg/kg i.p.) in a conditioned place preference (CPP) paradigm were studied (Medvedev et al 
2005). Because NR1-KD mice could eventually become sensitized to the locomotor-
stimulating effects of cocaine, the development of CPP was studied over time. During a pre-
test period, the time spent in each of two chambers was measured, and the less-preferred 
chamber for each mouse was selected for subsequent pairing with cocaine administration. 
On consecutive days cocaine or saline was paired with a specific chamber, and then on the 
third day following this pairing, place preference was measured. In accordance with the 
locomotor activity data, a single injection led to place preference in wildtype mice, whereas 
NR1-KD mice displayed little place preference at this point (Figure 8a). However, after 
repeated cocaine injections NR1-KD mice acquired almost the same level of CPP as 
wildtype mice, in line with our sensitization studies. Our results suggest that while the acute 
cocaine administration may be less rewarding in NR1-KD mice, repeated administration 
evokes the eventual development of sensitization and reward in these mice.
Conditioned place preference to 2 mg/kg amphetamine was measured with the same 
paradigm; however, neither wildtype nor NR1-KD mice displayed CPP when tested in this 
manner (data not shown). This was likely due to the interruption of conditioning days with 
test days. When the experiment was performed with six consecutive days of conditioning 
with alternating amphetamine (2 mg/kg) and saline, both wildtype mice and NR1-KD mice 
displayed significant place preference to the drug-paired chamber (Figure 8b).
Discussion
In this report, we have used a genetically altered mouse strain to demonstrate that reduced 
NMDA receptor expression markedly decreases the acute effects of cocaine on behavior and 
striatal gene expression. In contrast, the effects of another psychostimulant, amphetamine, 
were unchanged. This was somewhat surprising, since both drugs are thought to elicit most 
of their locomotor stimulant effects through a common mechanism, by increasing 
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extracellular dopamine concentrations in the striatum and nucleus accumbens via blockade 
or reversal of the dopamine transporter (Amara and Kuhar, 1993; Jones et al 1998; Sulzer et 
al 2005). In addition, behavioral responses to direct dopamine receptor agonists were 
unaltered, as was the ability of both cocaine and amphetamine to elevate extracellular 
dopamine in the striatum. The intact behavioral response to direct dopamine receptor 
agonists in NR1-KD mice provides the opportunity to identify the non-dopaminergic 
mechanisms essential for full expression of the acute actions of cocaine.
We observed significant reductions in NR2A and NR2B protein levels that resulted from 
NR1 deficiency. This is consistent with studies performed using mice with a regional 
deletion of the NR1 gene (Fukaya et al 2003). When NR1 deletion was restricted to regions 
including the CA1 region of the hippocampus, reductions in NR2A and NR2B protein were 
detected, but message levels from these genes were unchanged. It was suggested that the 
accumulated NR2 subunits are degraded through intracytosolic degradation by the 26S 
proteosome. It is likely that this phenomenon also explains the global reductions of NR2 
subunits that we observe in NR1-KD mice.
The behavioral pharmacology of NMDA receptor deficient mice underscores the differences 
in cocaine and amphetamine mechanism of action. It is known that cocaine's effects on 
dopamine accumulation are dependent on the firing of dopaminergic neurons (White 1990), 
whereas amphetamine's effects are not (Jones et al 1998). If dopaminergic neurons were 
firing less in NR1-KD mice, it would explain the differential effects of cocaine and 
amphetamine. This is not indicated by our results, which show that extracellular dopamine 
levels are similar in wildtype and mutant mice at basal levels and that cocaine elicits similar 
increases in extracellular dopamine concentration in wildtype and mutant mice. Measuring 
the total accumulation of dopamine after drug treatment does not, however, measure the 
quality of dopaminergic neuron firing.
Electrophysiological studies indicate that psychostimulants can induce burst firing of 
dopamine neurons, which is thought to encode information about the motivational value of a 
stimulus (Paladini et al 2001, 2003; Bonci et al 2003; Schultz 1998). Differences in chronic 
effects of cocaine and amphetamine may perhaps reflect a difference in the ability of these 
two drugs, in NMDA receptor deficient mice, to induce burst firing of dopamine neurons.
With regards to cocaine's acute effects, it is likely that cocaine induces behavioral 
hyperactivity and striatal immediate early gene expression not only by increasing dopamine 
levels in the striatal synapses, but also through the activation of the glutamatergic 
corticostriatal pathway, in response to elevated extracellular levels of dopamine, serotonin 
and norepinephrine in the prefrontal cortex (Tzshentke, 2001; Volkow and Fowler, 2000; 
Porrino and Lyons, 2000; Rocha et al 1998; Kuczneski et al 1991). An explanation for 
amphetamine's relative independence (compared to cocaine) from glutamatergic 
neurotransmission might be its high efficacy to release dopamine (Figure 3) as well as other 
monoamines. In this study we demonstrate that, at doses that elicit similar levels of 
locomotor activity, amphetamine elevates extracellular dopamine levels 2-3 times more than 
cocaine. This further supports the hypothesis of an additional, non-dopaminergic component 
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in the stimulatory effects of cocaine (Kuczenski et al 1991; Vanderschuren and Kalivas, 
2000).
Considering the body of evidence suggesting that blockade of NMDA receptors prevents the 
development of behavioral sensitization to psychostimulants, the diminished response to 
repeated administration of cocaine was not completely unexpected (Li et al 1999; Haracz et 
al 1995; Kalivas and Alesdatter, 1993; Stewart and Druhan, 1993; Wolf and Jeziorski, 1993; 
Heusner and Palmiter, 2005; Miyamoto Y et al 2004). More surprising was that some level 
of sensitization to cocaine still persisted and that amphetamine sensitization developed to the 
same extent in NR1 mutant animals as in wildtypes. It should be noted that sensitization to 
amphetamine for both genotypes was a reflection of the locomotor response to amphetamine 
relative to the locomotor response to saline, as habituation to the testing environment was 
observed in both genotypes.
One explanation for the ability of mutant animals to show any level of sensitization is that 
the remaining 10% of functional NMDA receptors are sufficient for sensitization to develop 
in NR1-KD mice. However, low doses of MK-801 (0.2-0.3 mg/kg) have been reported to 
disrupt sensitization (Li et al 1999; Haracz et al 1995; Kalivas and Alesdatter, 1993; Stewart 
and Druhan, 1993; Wolf and Jeziorski, 1993, Vanderschuren and Kalivas, 2000; Wolf 1998). 
At these doses in vivo, NMDA receptor occupancy and antagonism by MK-801 is only 
40-50% (Price et al 1998; Murray et al 2000). Perhaps these results instead illustrate the 
points of difference and similarity between acute pharmacologic NMDA receptor blockade 
and chronic genetic hypofunction of the NMDA receptor system. NR1 mutant animals have 
a sustained impairment in NMDA receptor function through development and adulthood, 
and the composition of the glutamatergic synapse is altered at the time when 
psychostimulants are first presented. The behavioral consequences of this alteration are most 
evident in the acute response to cocaine; however, with repeated exposure to cocaine, 
sensitization does occur, although its induction, or acquisition, is impaired compared to 
wildtype mice. The expression of sensitization, measured on the seventh day of the 
paradigm, is also reduced.
Although deficits in cocaine sensitization were evident in mutant animals, cocaine was still 
rewarding to NR1-KD mice as demonstrated in the CPP paradigm. Establishment of place 
preference was, however, slower in NR1-KD than wildtype animals. It was not possible to 
compare the development of cocaine and amphetamine with this same paradigm, because 
the temporal spacing and interruption of drug-paired exposures prevented robust CPP to 
amphetamine in wildtype animals using the specific design of this paradigm (data not 
shown). However, using a regimen of consecutive conditioning with alternating 
amphetamine and saline exposures, it was possible to measure amphetamine CPP, which 
occurred in wildtype and NR1-KD mice. These studies indicate that chronic NMDA 
receptor deficiency does not eliminate the rewarding effects of these psychostimulants.
The delay in the development of CPP to cocaine may indicate that the same processes 
underlying sensitization need to occur before cocaine is experienced as rewarding by NR1-
KD mice. Perhaps the repeated elevation of dopamine, which remains intact in NR1-KD 
mice, can eventually induce equivalent neurochemical changes that cocaine normally elicits 
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through the combination of NMDA receptor and dopamine receptor neurotransmission. An 
alternative explanation for the delayed performance in the CPP paradigm may be that these 
mice have difficulties associating environmental cues with the drug, as their spatial memory 
could be impaired due to decreased number of hippocampal NMDA receptors (Tsien et al 
1996).
In conclusion, the lack of obvious functional deficits in the brain dopamine system of NR1-
KD mice strongly suggest a specific role for glutamatergic NMDA receptor signaling in the 
acute actions of cocaine, making it clearly distinct from another psychostimulant, 
amphetamine. The substantial loss of acute response to cocaine is in contrast to the subtler 
deficits in sensitization and reward. The nature of these contrasting phenotypes is such that, 
with NMDA receptor deficent mice, we may dissect the contribution of the major 
neurotransmitter systems at different stages of the pathological progression leading to 
addiction.
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Protein levels of NMDA and AMPA receptor subunits in NR1-KD mice. (A) Representative 
western blots of 40 ug total protein extracts from the hippocampus of wildtype and NR1-KD 
mice. (B) Quantification of glutamate receptor subunit levels in the striatum, prefrontal 
cortex, and hippocampus measured by densitometry and normalized to actin. NR2A subunit 
levels in NR1-KD mice are reduced to 19%, 16%, and 12% of wildtype levels in the three 
brain regions respectively. NR2B subunit levels are reduced to 9%, 14%, and 7% of wildtype 
levels in the three brain regions respectively. Levels of AMPA receptor subunits GluR1 and 
GluR2/3 are unchanged. For each panel, n=4/group, **p < 0.01, ***p < 0.001 two-tailed t-
test. (C) Protein levels of NR1 and GluR1 in midbrain microdissections of substantia nigra/
ventral tegmentum. Tyrosine hydroxylase (TH) immunoreactivity was used to verify 
dissection of dopaminergic neurons. Quantification of NR1 and GluR1 levels measured by 
densitometry and normalized to TH. NR1 subunit is reduced to 9% in midbrain neurons, and 
GluR1 subunit levels are unchanged (p>0.05, two-tailed t-test).
Ramsey et al. Page 17














Locomotor stimulating effects of cocaine and amphetamine in wildtype (WT) and NR1-KD 
mice. (A) Dose-dependent increase in locomotor activity following treatment with different 
doses of cocaine was observed in WT, but not NR1-KD mice (saline, n=20/group; cocaine, 
n=8/group/dose). ***p < 0.001 compared to saline-treated WT (one-way ANOVA followed 
by Newman-Keuls test), (x0005E)p > 0.05 compared to saline treated NR1-KD (one-way 
ANOVA followed by Newman-Keuls test). ##p < 0.01 and ###p < 0.001 compared to WT 
mice treated with the same dose (two-tailed t-test). (B) Locomotor activity in WT and NR1-
KD mice after treatment with 40 mg/kg of cocaine (n=8/group). (C) Dose-dependent 
increase in locomotor activity following treatment with different doses of amphetamine was 
seen in both WT and NR1-KD mice (saline, n=8/group; amphetamine, n=8/group/dose). **p 
< 0.01, ***p < 0.001, ^p > 0.05 compared to saline-treated WT or NR1-KD mice (one-way 
ANOVA followed by Newman-Keuls test). (D) Locomotor activity in WT and NR1-KD 
mice after treatment with 3 mg/kg of amphetamine (WT, n=8; KD, n=9).
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Presynaptic dopamine function in wildtype (WT) and NR1-KD mice. (A) Effect of cocaine 
(20 mg/kg i.p.) and amphetamine (3 mg/kg i.p.) on extracellular DA levels in striata of WT 
and NR1-KD mice was measured by in vivo microdialysis in freely moving animals. Effect 
of saline treatment (WT-SAL and KD-SAL) is presented for comparison (cocaine, WT n=6, 
KD n=5; amphetamine, WT n=4, KD n=5; saline, WT n=5, KD n=6). Data are presented as 
a percentage of the mean of three basal samples collected prior to injection of the drug or 
saline. Basal dialysate concentrations of DA under present conditions were 41.7±7.3 (n=15) 
and 42.5±4.6 (n=16) fmol/20 μ l for WT and NR1-KD mice, respectively. Cocaine and 
amphetamine induced elevation of extracellular DA in both genotypes. There were no 
significant differences in responsiveness to cocaine or amphetamine between genotypes. (B) 
Dopamine transporter binding in striatal membranes from WT and KD mice measured using 
[3H]CFT in homologous competition assay (no difference; n=3/group).
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Dopamine receptor biochemistry and behavioral pharmacology. (A) D1 dopamine receptor 
levels, as assessed by [3H]SCH23390 binding to striatal membranes were unchanged in 
NR1-KD mice (n=4). (B) D2 dopamine receptor levels, as assessed by [3H]quinpirole 
binding to striatal membranes were unchanged in NR1-KD mice (n=4). (C) Treatment with 
direct D1 receptor agonist SKF-81297 increased locomotor activity in both WT and KD 
mice (saline, n=20; SKF-81297, n=8). Treatment with direct D2 receptor agonist quinpirole 
led to decreased locomotor activity in both WT and KD mice (saline, n=20; quinpirole, n=7) 
*p < 0.05, ***p < 0.001 compared to saline-treated mice of same genotype (one-way 
ANOVA followed by Newman-Keuls test), #p < 0.05 compared to saline-treated WT mice 
(two-tailed t-test).
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Effects of psychostimulants on c-fos protein expression in wildtype (WT) and NR1-KD 
mice. (A) Example of the pattern of c-fos expression 90 min after cocaine treatment (20 
mg/kg i.p.) in the dorsal part of striatum (+1.20 mm from bregma) of WT and NR1-KD 
mice. c-fos –positive nuclei are stained red, and medium spiny neurons belonging to the 
direct output pathway are stained green using μ-opioid receptor antibody. Scale bar is 100 
μm. (B) Number of c-fos positive neurons in dorsal striatum (+1.20 to +1.04 mm from 
bregma) is significantly lower in NR1-KD mice after cocaine (20 mg/kg i.p.) but not 
amphetamine (3 mg/kg i.p.) treatment, as compared to WT mice (n=4/group). **p < 0.01 
compared to cocaine-treated WT mice (two-tailed t-test). Drawing of coronal slice illustrates 
region of dorsal and ventral striatum.
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Behavioral sensitization to cocaine (A) Locomotor response of wildtype and NR1-KD mice 
on the first and last day of cocaine sensitization (20 mg/kg ip, n=14-15, mean±SEM). (B) 
Sum of locomotor response to cocaine or saline (1 hour post injection) during the 
sensitization paradigm (mean±SEM, n=14-15 for cocaine, n=8 for each genotype for saline). 
(C) Development of sensitization to cocaine with repeated exposure, expressed as fold 
activation above saline-treated animals of the same genotype (sum of distance traveled one 
hour post drug injection divided by sum of distance traveled one hour post saline injection). 
Analysis by one-way repeated measures ANOVA and Newman-Keuls post hoc test 
determines that wildtype mice first show significant increase (above day one) on the second 
day (*p<0.05). NR1-KD mice first show significant increase on the third day (#p<0.05). 
NR1-KD level of sensitization is reduced on day seven as compared to that of wildtype mice 
(two-tailed t-test, p<0.001).
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Behavioral sensitization to amphetamine (A) Locomotor response of wildtype and NR1-KD 
mice on the first and last day of amphetamine sensitization (2 mg/kg ip, n=7-8, mean±SEM). 
(B) Sum of locomotor response to amphetamine or saline (1 hour post injection) during the 
sensitization paradigm (mean±SEM, n=7-8 for amphetamine, n=8 for each genotype for 
saline). (C) Development of sensitization to amphetamine with repeated exposure, expressed 
as fold activation above saline-treated animals of the same genotype (sum of distance 
traveled one hour post drug injection divided by sum of distance traveled one hour post 
saline injection). Analysis by one-way repeated measures ANOVA and Newman-Keuls post 
hoc test determines that wildtype mice first show significant increase (above day one) on the 
fourth day (*p<0.05). NR1-KD mice first show significant increase on the second day 
(#p<0.05).
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Conditioned place preference for cocaine and amphetamine in wildtype and NR1-KD mice. 
Data are expressed as the difference (Δ) in time spent initially (preconditioning) and after 
drug exposure in the chamber paired with cocaine (20 mg/kg) or amphetamine (2 mg/kg). 
(A) Cocaine conditioning was spaced with testing to assess the development of CPP. 
Statistical analysis revealed a significant genotype×time interaction, indicating that KD mice 
acquired CPP significantly slower than WT mice (p < 0.05, two-way repeated measures 
ANOVA; n=10/group). KD mice differed significantly from WT mice after the first pairing, 
but not after the second or third pairing. *p < 0.05 compared to WT (non-paired two-tailed t-
test). (B) Amphetamine induced significant place-preference in both wildtype and NR1-KD 
mice. Two-way repeated measures ANOVA revealed a significant treatment effect, but no 
significant genotype effect or genotype×treatment interaction (n=9/group). Subsequent 
paired two-tailed t-test comparing pre-conditioning and post-conditioning for each genotype 
showed significant effect of amphetamine conditioning *p < 0.05.
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